Gemina Laboratories Ltd. — Form D
Gemina Laboratories Ltd. of Burnaby, A1, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-01. The offering totals $303K, of which $303K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-04-01
- Form: D
- Accession: 0000912282-24-000338
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $303K
- Amount sold: $303K
- Investors: 2
- Date of first sale: 2024-03-18
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-509168
Issuer
- Name: Gemina Laboratories Ltd.
- CIK: 0001940016
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Incorporated: 2017
- Address: 3600 Gilmore Way, Suite 302, Burnaby, A1, V5G 4R8
- Phone: (604) 763-3191
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Martin Cronin | Director | Vancouver, A1 |
| John Davies | Director | Burnaby, A1 |
| Brian Firth | Director | Burnaby, A1 |
| Bola Grace | Director | Burnaby, A1 |
| Rob Greene | Director | Burnaby, A1 |
| Martha Najib | Director | Burnaby, A1 |
| Brian Firth | Executive Officer | Burnaby, A1 |
| Rob Greene | Executive Officer | Burnaby, A1 |
| Michael Liggett | Executive Officer | Vancouver, A1 |
| Robert Greene | Director | New York, NY |
| Robert Greene | Executive Officer | New York, NY |
| John Davies | Executive Officer | Burnaby, A1 |
| Davis Rokoss | Director | Vancouver, A1 |
| Davis Rokoss | Executive Officer | Vancouver, A1 |
| James Tansey | Director | Vancouver, A1 |
| Mike Liggett | Executive Officer | Vancouver, A1 |
Other filings by this issuer (1)
More